Healthcare provider profile · identity verified

Laura M Webster, M.D.

Family Practice · VANCOUVER, WA · NPI 1679862726

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	616	186
Losartan Potassium	Losartan Potassium	447	140
Levothyroxine Sodium	Levothyroxine Sodium	378	110
Lisinopril	Lisinopril	365	107
Amlodipine Besylate	Amlodipine Besylate	275	90
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	257	79
Gabapentin	Gabapentin	238	77
Trazodone Hcl	Trazodone Hcl	218	73
Simvastatin	Simvastatin	199	55
Oxycodone Hcl	Oxycodone Hcl	175	45
Pantoprazole Sodium	Pantoprazole Sodium	175	65
Rosuvastatin Calcium	Rosuvastatin Calcium	166	52
Albuterol Sulfate Hfa	Albuterol Sulfate	162	61
Potassium Chloride	Potassium Chloride	162	57
Metformin Hcl	Metformin Hcl	160	52
Metoprolol Tartrate	Metoprolol Tartrate	160	50
Atenolol	Atenolol	144	43
Metoprolol Succinate	Metoprolol Succinate	143	41
Glipizide	Glipizide	131	47
Metformin Hcl Er	Metformin Hcl	130	42
Meloxicam	Meloxicam	127	44
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	105	37
Sertraline Hcl	Sertraline Hcl	97	28
Fluoxetine Hcl	Fluoxetine Hcl	96	32
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	95	29
Pradaxa	Dabigatran Etexilate Mesylate	90	34
Hydrochlorothiazide	Hydrochlorothiazide	89	31
Omeprazole	Omeprazole	89	29
Buspirone Hcl	Buspirone Hcl	87	24
Alendronate Sodium	Alendronate Sodium	84	30
Tramadol Hcl	Tramadol Hcl	84	23
Warfarin Sodium	Warfarin Sodium	81	21
Furosemide	Furosemide	76	30
Escitalopram Oxalate	Escitalopram Oxalate	73	23
Bupropion Xl	Bupropion Hcl	70	21
Estradiol	Estradiol	69	33
Citalopram Hbr	Citalopram Hydrobromide	66	23
Tamsulosin Hcl	Tamsulosin Hcl	65	20
Duloxetine Hcl	Duloxetine Hcl	62	17
Spironolactone	Spironolactone	62	21
Pravastatin Sodium	Pravastatin Sodium	61	21
Jardiance	Empagliflozin	59	20
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	57	18
Humulin N	Insulin Nph Human Isophane	56	20
Spiriva Respimat	Tiotropium Bromide	56	22
Triamcinolone Acetonide	Triamcinolone Acetonide	55	35
Lorazepam	Lorazepam	54	26
Ondansetron Odt	Ondansetron	54	18
Fluticasone Propionate	Fluticasone Propionate	49	17
Oxybutynin Chloride Er	Oxybutynin Chloride	49	15
Allopurinol	Allopurinol	45	13
Famotidine	Famotidine	45	16
Shingrix	Varicella-Zoster Ge/As01b/Pf	44	41
Wixela Inhub	Fluticasone Propion/Salmeterol	43	18
Humulin R	Insulin Regular, Human	42	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	39	suppressed
Mirtazapine	Mirtazapine	38	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	38	suppressed
Methocarbamol	Methocarbamol	37	15
Montelukast Sodium	Montelukast Sodium	37	15
Nystatin	Nystatin	37	19
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	35	13
Prednisone	Prednisone	33	26
Terazosin Hcl	Terazosin Hcl	33	12
Venlafaxine Hcl Er	Venlafaxine Hcl	33	14
Bupropion Hcl Sr	Bupropion Hcl	31	12
Ozempic	Semaglutide	31	suppressed
Topiramate	Topiramate	31	13
Alprazolam	Alprazolam	30	suppressed
Alvesco	Ciclesonide	30	15
Acetaminophen-Codeine	Acetaminophen With Codeine	28	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Donepezil Hcl	Donepezil Hcl	27	suppressed
Lovastatin	Lovastatin	27	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	27	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	13
Hydroxyzine Hcl	Hydroxyzine Hcl	25	suppressed
Ibuprofen	Ibuprofen	25	14
Carvedilol	Carvedilol	24	suppressed
Levetiracetam	Levetiracetam	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Pregabalin	Pregabalin	23	suppressed
Propranolol Hcl	Propranolol Hcl	23	suppressed
Tenivac	Tetanus-Diphtheria Toxoids/Pf	23	23
Baclofen	Baclofen	22	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	22	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	17
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Tizanidine Hcl	Tizanidine Hcl	22	12
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	22	suppressed
Clopidogrel	Clopidogrel Bisulfate	21	suppressed
Ketoconazole	Ketoconazole	21	suppressed
Acyclovir	Acyclovir	19	suppressed
Torsemide	Torsemide	19	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	19	suppressed
Finasteride	Finasteride	18	suppressed
Hydrocortisone	Hydrocortisone	18	suppressed
Ipratropium Bromide	Ipratropium Bromide	18	13
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Amoxicillin	Amoxicillin	17	15
Lactulose	Lactulose	17	suppressed
Metronidazole	Metronidazole	17	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	17	suppressed
Methylprednisolone	Methylprednisolone	16	14
Xarelto	Rivaroxaban	16	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	15	15
Clonidine Hcl	Clonidine Hcl	15	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	15	11
Glipizide Er	Glipizide	15	suppressed
Latanoprost	Latanoprost	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Naproxen	Naproxen	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Cephalexin	Cephalexin	14	11
Yuvafem	Estradiol	14	suppressed
Cartia Xt	Diltiazem Hcl	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Haloperidol	Haloperidol	13	suppressed
Junel Fe	Norethindrone-E.Estradiol-Iron	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Budesonide Dr	Budesonide	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Cefadroxil	Cefadroxil	11	11
Fenofibrate	Fenofibrate	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Lubiprostone	Lubiprostone	11	suppressed
Methadone Hcl	Methadone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error